| Australia |
HHS |
Aug 1, 1976 |
Termination date:
Indefinite |
Funding not
specified |
NIH National
Library of Medicine MEDLARS Agreement with the National
Library of Australia. Quid pro quo interlibrary exchange. |
| Australia |
HHS (FDA) |
Nov 28, 1979 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the Australian Department of Primary Industry and
U.S.'s FDA. To assure that dry milk products from
Australia are free from contamination or underprocessing
and to minimize the need for extensive sampling at U.S.
ports through utilizing agreed upon sampling and
certification methodologies and safety standards. |
| Australia |
HHS (FDA) |
Sep 12, 1986 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs John
Taylor, between the Australian Export Inspection Service,
Department of Primary Industry and U.S.'s FDA. To utilize
the same sanitary principles and procedures for
certification, to share compliance information, and to
facilitate inspections of handling facilities and growing
areas for shellfish products exported to the U.S. |
| Austria |
HHS |
Aug 13, 1993 |
Aug 12, 1998 |
Funding not
specified |
Agreement between
NIH and Austrian Science Foundation for the support of
biomedical scientist exchanges. |
| Belgium |
HHS (FDA) |
Nov 6, 1974 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Alexander Schmidt, between Belgium's
National Dairy Office of the Ministry of Agriculture and
U.S.'s FDA. To assure that dry milk products from Belgium
are free from contamination or underprocessing and to
minimize the need for extensive sampling at U.S. ports
through utilizing agreed upon sampling and certification
methodologies and safety standards. |
| Botswana |
HHS |
Feb 22, 1995 |
Feb 22, 1998 |
Funded by CDC to
the extent of available appropriations. |
Executive agent for
the U.S.: CDC of HHS/PHS. Executive agent for Botswana:
the Ministry of Health of Botswana. Cooperation on
tuberculosis control...epidemiologic support to Botswana
National Tuberculosis Programme, conduct operational
research to improve tuberculosis treatment and prevention
programs, to study the issues related to the interaction
between tuberculosis and human immunodeficiency virus
infection, and to strengthen tuberculosis laboratory
capabilities in Botswana. IPR Annex. |
| Brazil |
HHS |
Jan 1, 1977 |
Termination date:
Indefinite |
Funding not
specified |
NIH/National
Library of Medicine MEDLARS Agreement with Centro Latino
Americano de Informaciao em Cienceas de Salude (BIREME);
quid pro quo interlibrary exchanges. |
| Canada |
HHS |
Dec 16, 1974 |
Termination date:
Indefinite |
Funding not
specified |
MOU between FDA and
Canada's Health Protection Branch, to exchange
information on compliance program efforts in controlling
radiation emission and human exposure from electronic
products. |
| Canada |
HHS |
Jul 30, 1970 |
Termination date:
Indefinite |
Funding not
specified |
NIH/National
Library of Medicine. MEDLARS Agreement with Canada
Institute for Scientific and Technical Information
(CISTI); quid pro quo interlibrary exchange. |
| Canada |
HHS (FDA) |
Apr 30, 1948 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by the
Canadian Department of National Health and Welfare and
U.S's. Department of State and FDA. To utilize the same
sanitary principles and procedures for certification, to
share compliance information, and to facilitate
inspections of handling facilities and growing areas for
shellfish products exported to the U.S. |
| Canada |
HHS (FDA) |
Jul 26, 1988 |
Jul 26, 1998 |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Canadian Medical
Services Branch, Department of National Health and
Welfare, and U.S.'s FDA. To Cooperate and to administer
one another's safety standards and methods in the
monitoring of food, beverage, and sanitary services
provided on common carriers operating between Canada and
the U.S. |
| Chile |
HHS (FDA) |
May 18, 1989 |
May 18, 1999 |
Funding not
specified |
MOU, signed by FDA
Commissioner James Benson, between the Chilean Ministry
of Economy Development and Reconstruction, Subsecretariat
of Fisheries and U.S.'s FDA. To utilize the same sanitary
principles and procedures for certification, to share
compliance information, and to facilitate inspections of
handling facilities and growing areas for shellfish
products exported to the U.S. |
| Chile |
HHS (FDA) |
Oct 27, 1989 |
Oct 27, 1999 |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Chilean
Agricultural and Livestock Service, Ministry of
Agriculture and U.S.'s FDA. To establish and implement
emergency procedures to ensure the safety of fresh fruit
export to the U.S. from Chile. |
| China |
HHS |
May 24, 1993 |
May 23, 1998 |
Funding not
specified |
Health Protocol
(MOU) between HHS and China's Ministry of Public Health
for Cooperation in the S&T of Medicine and Public
Health. Concerns: Disease control and prevention, public
health protection, biomedical research, health sciences
and health policy research, and health administration.
Supercedes protocol with same title that entered into
force 6/22/79. |
| China |
HHS |
Mar 13, 1991 |
Mar 12, 1994 |
Funding not
specified |
MOU between the
National Institute of Neurological Disorders and Stroke,
NIH, and the Shanghai Brain Research Institute, Chinese
Academy of Sciences, for cooperation in neurosciences
research. The original MOU entered into force on 6/28/83.
The present MOU remained in force until 3/12/94 and is
on-going, unless terminated in writing. |
| China |
HHS |
Sep 7, 1987 |
Jun 30, 1992 |
Funding not
specified |
MOU between the
National Eye Institute, NIH, and the Zhongshau Opthalmic
Center at Zhongshao Medical University for cooperation in
vision research. The remained in force until 9/6/92. It
is under renewal process. |
| China |
HHS |
May 11, 1983 |
Self-renewing
agreement every 5 years. |
Funding not
specified |
MOU between HHS/NIH
and Chinese Academy of Sciences (CAS) for cooperation in
basic biomedical sciences; exchanges, research. |
| China |
HHS (CDC) |
Mar 14, 1991 |
Mar 13, 1998 |
Funding not
specified |
MOU between the
Centers for Disease Control and Prevention (CDC) and the
Beijing Medical University of the People's Republic of
China (PRC) to conduct a joint US PRC study of the
effectiveness of 0.4 mg of folic acid taken daily before
and during the 1st trimester of pregnancy to prevent
spina bifida and anencephaly. The study will involve
collaborative epidemiologic, laboratory, and analytical
research. |
| China |
HHS (FDA) |
Dec 26, 1988 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Chinese State
Administration of Import and Export Commodity Inspection
and U.S.'s FDA. To establish and implement certification
procedures to assure the safety of ceramicware intended
for use in the preparation, serving, or storage of food
or drink and offered for export to the U.S. |
| Colombia |
HHS |
Mar 12, 1981 |
Termination date:
Indefinite |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with the Pan American
Federation of Associations of Medical Schools; quid pro
quo interlibrary exchanges. |
| Cote D'Ivoire |
HHS (CDC) |
Aug 23, 1995 |
Aug 22, 2005 |
Funding not
specified |
Centers for Disease
Control and Ministry of Health collaboration in HIV 1 and
HIV 2 epidemiology, laboratory surveillance and research.
IPR Annex. |
| Denmark |
HHS (FDA) |
Jan 19, 1979 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the Danish State Quality Control for Dairy
Products and Eggs and U.S.'s FDA. To assure that dry milk
products from Denmark are free from contamination or
underprocessing and to minimize the need for extensive
sampling at U.S. ports through utilizing agreed upon
sampling and certification methodologies and safety
standards. |
| Egypt |
HHS |
Jan 1, 1982 |
Sep 30, 1997 |
AID funded. |
Under renewal
process. AID-funded NIAID, NIH program under the
congressionally-mandated Middle East Regional Cooperative
Program established following the Camp David Accord;
epidemiological and immunologic studies on vector-borne
diseases and cardiovascular diseases. |
| European Union |
US Gov (DOS) |
Sep 7, 1990 |
Sep 7, 1995 |
Funding not
specified |
Establishes
administrative arrangement for US/EC Joint Task Force on
Biotechnology research. |
| European Union |
US Gov (DOS) |
Sep 7, 1990 |
Sep 7, 2001 |
Each party bears
costs of their representatives. |
Establishes
administrative arrangement for US/EC Joint Task Force on
Biotechnology research. Renewed June 7, 1996 for five
years by the EC and Dr. Gibbons of OSTP, to carry on this
framework , mechanism for exchange of information
regarding scientific aspects of biotechnology between the
EC and the U.S. |
| Finland |
HHS |
Nov 5, 1982 |
On-going agreement |
Funding not
specified |
MOU between the
U.S. National Institute of Environmental Health Sciences
and the Finnish Institute of Occupational Health.
Activities include: metabolism of toxic agents and
pharmacokinetics; reproductive toxicology, including the
effects of physical factors on reproduction;
neurobehavioral toxicology, genetic toxicology and
chemical carcinogenesis; risk assessment methodology;
environmental epidemiology; planning, implementation, and
evaluation of national research programs in toxicology
and strategies for priority items. |
| Finland |
HHS (CDC &
NIOSH) |
Jun 11, 1992 |
Termination date:
Indefinite |
Each project funded
separately by parties involved. |
MOU on
Collaboration between NIOSH/CDC and the Finish Institute
of Occupational Health (IOH). Areas of cooperation
include, but are not limited to, occupational accidents
and injuries, industrial hygiene and control technology,
work physiology and ergonomics, and health services
research and development of occupational health services. |
| Finland |
HHS (FDA) |
Mar 4, 1984 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by
FDA's Center for Food Safety and Applied Nutrition
Director Stanford Miller, between the Finnish Board of
Customs and U.S.'s FDA. To establish and implement
certification procedures to assure the safety of certain
food products (puddings, soups, candies, chocolate and
chocolate liquor, cocoa powder and press cake , and wheat
flour) offered for export to the U.S. |
| France |
HHS |
Dec 20, 1974 |
On-going agreement |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with the French Institute of
Health and Medical Research; quid pro quo interlibrary
exchanges. |
| France |
HHS (FDA) |
Mar 18, 1986 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the French Ministry of Social Affairs and
National Solidarity, Office of Pharmaceuticals and
Medicines and U.S.'s FDA. To implement programs of
inspection of good laboratory practices for non-clinical
labs and to rely upon each country's findings in
evaluating the labs and the data from studies conducted
by these labs. |
| France |
HHS (FDA) |
Jan 15, 1987 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs John
Taylor, between the French Ministry of Agriculture and
U.S.'s FDA. To assure that casein products from France
are free from contamination or underprocessing and to
minimize the need for extensive sampling at U.S. ports
through utilizing agreed upon sampling and certification
methodologies and safety standards. |
| Germany |
HHS |
Oct 8, 1974 |
Termination date:
Indefinite |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with the FRG Institute of
Medical Documentation and Information; quid pro quo
interlibrary exchanges. BMFT has written to HHS for
extension. |
| Germany |
HHS |
Oct 9, 1981 |
Sep 1, 1992 |
Funding not
specified |
MOU between HHS,
NIH, and Ministry of Research and Technology in
cardiovascular, pulmonary and diseases, cancer,
arthritis, AIDS research, etc. Under negotiation for
renewal; the German Ministry wished to renew. |
| Germany |
HHS (FDA) & EPA |
Dec 23, 1988 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young and EPA Administrator Lee
Thomas, between the German Federal Minister of Food,
Agriculture and Forestry, the Federal Minister for Youth,
Family Affairs, Women and Health and the Federal Minister
for the Environment, Nature Conservation and Nuclear
Safety and U.S.'s EPA and FDA. To implement programs of
inspection of good laboratory practices for non-clinical
labs and to accept each country's findings in evaluating
the labs and the data from studies conducted by these
labs. |
| Hungary |
HHS |
Feb 23, 1981 |
Termination date:
Indefinite |
Funding not
specified |
Agreement between
the National Cancer Institute and the Hungarian National
Institute of Oncology for cancer research. |
| Iceland |
HHS (FDA) |
Dec 28, 1978 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Donald Kennedy, between the Icelandic
Ministry of Fisheries and U.S.'s FDA. To utilize the same
sanitary principles and procedures for certification, to
share compliance information, and to facilitate
inspections of handling facilities and growing areas for
shellfish products to be exported to the U.S. |
| India |
HHS (PHS) |
Jul 1, 1987 |
Activity continues
in some projects. |
Funding not
specified |
Vaccine Action
Program. Vaccine and immunodiagnostics development;
vaccine quality control; immunization programs
developments. |
| Israel |
HHS |
Jan 29, 1980 |
May 6, 2000:
On-going agreement |
Funding not
specified |
Agreement between
HHS and the Israeli Ministry of Health; covers areas of
health manpower and services, health services delivery,
health information system, food and drugs, public health
and biomedical research including mental health. |
| Italy |
HHS |
Nov 13, 1981 |
Termination date:
Indefinite |
Funding not
specified |
MOU between
National Heart, Lung, and Blood Institute, NIH, and the
Pharmocological Institute, University of Milan. |
| Italy |
HHS |
Dec 19, 1988 |
On-going agreement |
Funding not
specified |
MOU on good
laboratory practice. It may be terminated any time by
written notice to the other party. |
| Italy |
HHS |
Mar 12, 1985 |
Termination date:
Indefinite |
Funding not
specified |
MOU between
National Eye Institute and the Italian Ministry of
Health. |
| Italy |
HHS |
Nov 21, 1977 |
Renewable every 3
years. |
Funding not
specified |
MOU between HHS and
the Italian Ministry of Health in health and biomedicine.
Covers environmental health, cardiovascular and pulmonary
diseases, cancer, biomedical communication, infectious
disease, alcohol related problems. |
| Italy |
HHS |
Aug 2, 1978 |
Termination date:
Indefinite |
Funding not
specified |
Exchange of
information. Interlibrary exchange; Italian ISS is
counterpart to U.S. National Library of Medicine. |
| Japan |
HHS |
May 14, 1974 |
Self-renewing
agreement |
Funding not
specified |
This MOU with
National Cancer Institute (NCI) and the Japan Society for
the Promotion of Science (JSPS) of 4/24/73 was followed
by the Agreement on Cooperation in cancer research
between NCI and JSPS of 5/14/74. Activities that may be
supported under this MOU and Agreement are scientific
seminars, exchanges of personnel, and exchanges of
material and information. The agreement continues until
either party gives notification of intention to
terminate, but it should be evaluated for renewal every 5
years. |
| Japan |
HHS |
Apr 1, 1976 |
Apr 1, 1997:
Self-renewing agreement every 3 years. |
Funding not
specified |
Vision research;
National Eye Institute (NIH/NEI) and Japan Society for
the Promotion of Science. |
| Japan |
HHS |
Apr 13, 1965 |
Termination date:
Indefinite |
Funding not
specified |
US Japan
Cooperative Medical Sciences Program; cooperative
programs divided into 10 panels: Cholera and like
diarrheas, Immunology, Leprosy/Hansen's Disease,
Malnutrition, Parasitic diseases, Tuberculosis, viral
diseases, environmental mutagenesis and carcinogenesis,
viral hepatitis, and AIDS, and there is one board on
Immunology. |
| Japan |
HHS |
May 1, 1990 |
Termination date:
Indefinite |
Funding not
specified |
MOU between the
National Institute on Deafness and Other Communicative
Diseases, NIH, and the Department of Otolaryngology of
Kurume University for cooperation on ear, nose, throat,
speech and voice research. |
| Japan |
HHS |
Sep 1, 1990 |
Termination date:
Indefinite |
Funding not
specified |
Agreement between
the National Institute on Deafness and Other
Communicative Disorders, NIH, and the Department of
Otolaryngology of Tokushima University. |
| Japan |
HHS |
|
Termination date:
Indefinite |
Funding not
specified |
The National Cancer
Institute, NIH, and Japan Foundation for Cancer Research
establish research training program for U.S. scientists
to receive training at Japanese cancer research
insitutions and vice versa. |
| Japan |
HHS |
Sep 1, 1984 |
Self-renewing
agreement |
Funding not
specified |
Gerontology
research; National Institute on Aging works with Tokyo
Metropolitan Institute of Gerontology on biomedical
research on aging and the elderly. Next evaluation to
consider renewal scheduled for 11/22/96. |
| Japan |
HHS |
Jan 1, 1974 |
Termination date:
Indefinite |
Funding not
specified |
MOU between the
National Library of Medicine (MEDLARS) and the Japan
Information Center for S&T (JICST) for cooperation in
the use and further development of the Medical Literature
Analysis and Retrieval System (MEDLARS) deveoped by NLM
(National Library of Medicine). This MOU gives JICST
exclusive rights for the use of MEDLARS in Japan. |
| Japan |
HHS (FDA) |
Oct 24, 1962 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by U.S.
Surgeon General Luther Terry, between the Japanese
Ministry of Health and Welfare and U.S.'s FDA. To utilize
the same sanitary principles and procedures for
certification, to share compliance information, and to
facilitate inspections of handling facilities and growing
areas for shellfish products traded between the two
countries. |
| Korea |
HHS |
Jan 1, 1988 |
Oct 26, 1996 |
Funding not
specified |
MOU between the
National Cancer Institute, NIH, and the Korean Academy of
Medical Sciences encouraging/permitting seminars,
exchanges of personnel and research materials, etc. |
| Mexico |
HHS |
Oct 17, 1994 |
Oct 16, 1999 |
Funding not
specified |
The establishment
of a cooperative biomedical research program between NIH
and the National Council for Science and Technology of
Mexico (CONACYT). Covers all NIH research areas. Provides
cost-sharing for research development workshops and
support for up to 6 postdoctoral Mexican scientists for
up to 2 years of research and advanced training at NIH. |
| Mexico |
HHS |
Nov 14, 1986 |
Termination date:
Indefinite |
Funding not
specified |
The establishment
of cooperation between NIH and the Center for Advanced
Studies in S&T in the National Polytechnic Institute
of Mexico. covering all NIH areas for information
exchange, advanced training and research cooperation as
funding permits. |
| Mexico |
HHS |
May 7, 1996 |
May 6, 2001 |
Funding not
specified |
Agreement for
cooperation in the field of health between the U.S. and
Mexico. |
| Mexico |
HHS |
Mar 11, 1982 |
Termination date:
Indefinite |
Funding not
specified |
An agreement for
scientific cooperation on alcohol related problems,
between the National Institute on Alcohol Abuse and
Alcoholism (NIAA), ADAMHA, and the Mexican Institute of
Psychiatry. |
| Mexico |
HHS |
Jun 30, 1976 |
Termination date:
Indefinite |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with Centro Nacional de
Informacion y Documentacion en Salud (CENIDS); quid pro
quo interlibrary exchange. SAMSHA program interests in
mental health and substance abuse in U.S. Mexico Border
Initiative. |
| Mexico |
HHS |
Feb 22, 1988 |
Feb 22, 1998 |
Funding not
specified |
MOU between FDA and
Mexico's Ministry of Health to exchange information and
establish mechanism for cooperation in the scientific and
regulatory fields of health. MOU refers to the areas of:
foods, drugs, cosmetics, biologics (blood and blood
products), and medical devices. |
| Mexico |
HHS |
Nov 1, 1992 |
Oct 31, 1997:
Termination date: Indefinite |
Funding not
specified |
Plan for Scientific
Cooperation between NIH and Center for Research and
Advanced Studies, National Polytechnic Institute, Mexico
(CINVESTAV IPN); covers neurosciences and endocrinology,
neurobiology and anaesthesiology, molecular aging, liver
metabolism. |
| Mexico |
HHS (FDA) |
Nov 12, 1988 |
Nov 12, 1998 |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Mexican Secretariat
of Health and U.S.'s FDA. To share compliance
information, and to facilitate inspections of handling
facilities and growing areas for shellfish products
exported to the U.S. |
| Mexico |
HHS (FDA) |
Nov 28, 1988 |
Nov 28, 1998 |
Funding not
specified |
MOU, signed by U.S.
Ambassador Charles Pilliod, between the Mexican General
Directory of Agriculture and Water Resources and U.S.'s
FDA. To exchange information, collaborate, and develop
programs concerning the certification and regulation of
raw agricultural products in trade between the two
countries. |
| Mexico |
HHS (FDA) |
Feb 22, 1988 |
Feb 22, 1998 |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Mexican Secretaria
de Salud and U.S.'s FDA. To exchange information,
collaborate, and develop scientific and regulatory
programs concerning the safety of foods, drugs,
cosmetics, biologics, and medical devices. |
| Mongolia |
HHS (CDC) |
Jan 23, 1991 |
Jan 22, 2001 |
Funding not
specified |
Agreement renewed
for an additional 5 years from Jan. 22, 1996 to Jan. 22,
2001. Provides for the exchange of scientific and
technical information and cooperation between the United
States and Mongolia for activities in health and the
earth sciences through MOU's with the HHS/Centers for
Disease Control and Prevention and the U.S. Geological
Survey. |
| Multilateral |
HHS |
Sep 23, 1993 |
Sep 23, 1996 |
Funding not
specified |
MOU between the
Agency for Toxic Substances and Disease Registry (ATSDR)
and the Pan American Health Organization (PAHO/WHO) for
collaboration in environmental public health program
areas pertaining to hazardous substances of mutual
interest and concern. |
| Netherlands, The |
HHS (FDA) |
Dec 20, 1988 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Dutch Ministry of
Welfare, Health and Cultural Affairs, and U.S.'s FDA. To
implement programs of inspection of good laboratory
practices for non-clinical labs and to rely on each
country's findings in evaluating the labs and the data
from studies conducted by these labs. |
| Netherlands, The |
HHS (FDA) |
Jan 8, 1982 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the Dutch Directorate General for Agriculture and
Food, the Ministry of Agriculture and Fisheries, and
U.S.'s FDA. To assure that dry milk products from the
Netherlands are free from contamination or
underprocessing and to minimize the need for extensive
sampling at U.S. ports fthrough utilizing agreed upon
sampling and certification methodologies and safety
standards (including a July 7, 1982 amendment). |
| New Zealand |
HHS (FDA) |
Nov 11, 1975 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed FDA
Deputy Commissioner Sherwin Gardner, between the New
Zealand Ministry of Agriculture and Fisheries and U.S.'s
FDA. To assure that dry milk products from the
Netherlands are free from contamination or
underprocessing and to minimize the need for extensive
sampling at U.S. ports through utilizing agreed upon
sampling and certification methodologies and safety
standards. |
| New Zealand |
HHS (FDA) |
Oct 30, 1980 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the New Zealand Ministry of Agriculture and
Fisheries and U.S.'s FDA. To share compliance
information, and to facilitate inspections of handling
facilities and growing areas for shellfish products
exported to the U.S. |
| Norway |
HHS (FDA) |
Feb 26, 1982 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the Norwegian Ministry of Agriculture and U.S.'s
FDA. To assure that rennet casein from Norway is free
from contamination or underprocessing and to minimize the
need for extensive sampling at U.S. ports through
utilizing agreed upon sampling and certification
methodologies and safety standards. |
| Philippines, the |
HHS (FDA) |
Sep 18, 1986 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Center for Food Safety and Applied Nutrition Director
Sanford Miller, between the Philippine National Food
Authority and U.S.'s FDA. To utilize the same sanitary
principles and procedures for certification, to share
compliance information, and to facilitate inspections of
manufacturing facilities shrimp, fruit, and fruit purees
exported to the U.S. |
| Poland |
HHS |
Mar 14, 1962 |
Termination date:
Indefinite |
Funding not
specified |
Agreement for
cooperation in the field of health between the U.S. and
Poland. Renegotiated and newly signed in September 1987. |
| Poland |
HHS |
Oct 1, 1984 |
Termination date:
Indefinite |
Funding not
specified |
Agreement with
Polish Ministry of Health and Social Welfare; cooperation
on mental health and alcohol related health problems;
cardiovascular & pulmonary diseases, individual
health scientist exchanges, cancer research, mental
health, child health, & applied nutrition. |
| Poland |
HHS |
Oct 8, 1976 |
Oct 8, 1992:
On-going agreement |
Funding not
specified |
Renewed date:
10/08/87. Agreement between National Cancer Institute and
Polish National Institute of Oncology. Epidemiological,
basic, and clinical investigations in the field of
cancer. |
| Regional |
HHS |
Oct 26, 1977 |
Termination date:
Indefinite |
Funding not
specified |
NIH/National
Library of Medicine MEDLARS Agreement for interlibrary
exchanges. |
| Russia |
HHS |
Jun 28, 1974 |
Jun 28, 1999:
Self-renewing agreement every 5 years. |
Funding not
specified |
Agreement between
NHLBI and Ministry of Health, All Union Center for
Cardiological Research, for cooperation on artificial
heart research and development. |
| Russia |
HHS (FDA) |
Feb 2, 1994 |
Feb 2, 1997 |
Funding not
specified |
MOU, signed by FDA
Commissioner David Kessler and FDA Deputy Commissioner
Mary Pendergast, between the Russian Ministry of Health
and Medical Industry and the State Committee for Sanitary
and Epidemiological Surveillance and U.S's FDA. To
cooperate and exchange information in the area of drug
and biological products and for Russian authorities to
accept FDA decisions and regulations on premarket
approval, licensing, monographs, and related matters
(including a Statement on the revised annex to this
agreement signed by FDA Deputy Commissioner Mary
Pendergast and HHS Secretary Donna Shalala on 1/20/96). |
| Russia |
HHS (PHS) |
Jun 23, 1994 |
Jun 22, 1999:
Self-renewing agreement every 5 years. |
|
MOU to promote
biomedical research cooperation. NIH is U.S. Executive
Agent and the Academy of Sciences of the Russian
Federation is the Russian Executive Agent. Initial areas
of cooperation include: Cancer, Immunology and AIDS,
Molecular Biology and Genetics, Neurobiology, Clinical
Research, and related S&T Info Exchange. Obligations
to this MOU subject to availability of funds. IPR
protected. |
| Russia |
US Gov (HHS) |
Jan 14, 1994 |
Jan 14, 1999 |
Funding not
specified |
Agreement on
Cooperation in the Fields of Public Health and Biomedical
Research including: Disease control and prevention,
public health protection, biomedical research, health
services and health policy research, and health
administration and finance. Joint activities, whenever
possible, will be coordinated with or support
activities/goals of international health bodies like the
World Health Organization. The implementing agency is the
U.S. Dept. of Health and Human Services. In the Russian
Federation the implementing agencies are: The Ministry of
Health and Medical Industry of the Russian Federation,
the State Committee for Sanitary and Epidemiological
Surveillance of the Russian Federation, and the Russian
Academy of Medical Services. |
| Saudi Arabia |
HHS |
Sep 1, 1974 |
Feb 12, 2000 |
Funded by Saudi
owned U.S. dollars in JECOR Account at U.S. Treasury. |
Under U.S. Saudi
Arabian Joint Commission Technical Cooperation Agreement;
shares knowledge and transfers technology in emergency
medical services (HRSA) and drug control (FDA). FDA's
Drug Control Project (DRUGCON) strengthens the Saudi
registration systems for pharmaceuticals, biologics and
related projects. Joint Commission Technical Cooperation
Agreement. |
| Sweden |
HHS |
Oct 20, 1974 |
Termination date:
Indefinite |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with Karolinska Institute;
quid pro quo interlibrary exchange. |
| Sweden |
HHS (FDA) |
Nov 7, 1977 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Donald Kennedy, between the Swedish
Government Control Board of Dairy Products and U.S.'s
FDA. To assure that dry milk products from Sweden are
free from contamination or underprocessing and to
minimize the need for extensive sampling at U.S. ports
through utilizing agreed upon sampling and certification
methodologies and safety standards. |
| Sweden |
HHS (FDA) |
Oct 17, 1972 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Charles Edwards, between the Swedish
National Board of Health and U.S.'s FDA. To mutually
recognize inspections of drug manufacturing plants as
programmed and conducted by the respective agencies. |
| Switzerland |
HHS |
Nov 13, 1992 |
Nov 12, 1995 |
Funding not
specified |
Collaboration in
the International Programme on Chemical Safety. |
| Switzerland |
HHS |
Feb 21, 1980 |
|
Funding not
specified |
Termination date:
Indefinite. National Library of Medicine MEDLARS
Agreement with the Documentation Service of the Swiss
Academy of Medical Sciences; quid pro quo interlibrary
exchange. |
| Switzerland |
HHS (FDA) |
Oct 28, 1968 |
Termination date:
Indefinite |
|
Agreement signed by
U.S. Secretary of State Dean Rusk, between the U.S.'s FDA
and Switzerland, to recognize the Swiss drug inspection
system as equivalent to the FDA drug inspection system. |
| Switzerland |
HHS (FDA) |
Apr 29, 1985 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Commissioner Frank Young, between the Swiss Federal
Office for Foreign Economic Affairs, Federal Department
of Public Economy and U.S.'s FDA. To implement programs
of inspection of good laboratory practices for
non-clinical laboratories and to rely on each country's
findings in evaluating the labs and the data from studies
conducted by these labs. |
| Taiwan |
HHS |
Aug 24, 1989 |
Termination date:
Indefinite |
Funding not
specified |
Original Agreement
dated 5/21/84. Coordinated by the Coordinating Council
for North American Affairs, for cooperation between the
NIH and the National Science Council of Taiwan which
supports contacts and cooperation between biomedical
scientists, health professionals, and institutions of
scientific research. |
| Taiwan |
HHS (CDC) |
Jun 30, 1994 |
Termination date:
Indefinite |
Funding not
specified |
A Cooperative
Science Agreement signed by the American Institute in
Taiwan (AIT) for the U.S. and the Coordination Council
for North American Affairs under P.L. 96 8, 1979 Taiwan
Relations Act. Cooperation in areas like: cancer,
cardiovascular disease, infectious disease, environmental
health, and neurological study of stroke. AIT works in
association with CDC in administering the program. |
| Taiwan |
HHS (PHS) |
Oct 26, 1994 |
Termination date:
Indefinite |
Funding not
specified |
Agreement between
HHS/PHS/OIH and the American Institute in Taiwan (AIT)
provides technical expertise, training, and scientific
exchanges to AIT under its Agreement with the
Coordination Council for North American Affairs (CCNAA)
in vaccine and immunization-related activities. |
| Thailand |
HHS |
Jan 1, 1989 |
May 27, 1995 |
Funding not
specified |
Renewed in 1992.
MOU between NIH and Chulabhorn Research Institute in
Bangkok. |
| Thailand |
HHS (CDC) |
Aug 8, 1994 |
Aug 7, 1999 |
Funding not
specified |
The Executive agent
for the U.S.: CDC of HHS/PHS. The Executive agent for
Thailand: Ministry of Public Health (MOPH) of the Royal
Thai Government. Collaboration in HIV 1 and HIV 2
epidemiology, laboratory surveillance and research.
Initial priorities include: intravenous drug users,
female and male prostitutes, and monitoring the spread of
the HIV epidemic in the general population and sentinel
sub-populations by adapting and implementing national
seroprevalence surveys. Salaries and financial
obligations spelled out in MOU. IPR Annex. |
| United Kingdom |
HHS |
Jun 25, 1974 |
Termination date:
Indefinite |
Funding not
specified |
National Library of
Medicine MEDLARS Agreement with the British Library; quid
pro quo interlibrary exchange. |
| United Kingdom |
HHS (FDA) |
Sep 7, 1982 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the U.K. Department of Social Security and U.S.'s
FDA. To share compliance information, and to facilitate
inspections of handling facilities and growing areas for
shellfish products exports to the U.S. |
| United Kingdom |
HHS (FDA) |
Jun 6, 1986 |
Termination date:
Indefinite |
Funding not
specified |
MOU, signed by FDA
Associate Commissioner for Regulatory Affairs Paul Hile,
between the U.K. Department of Social Security and U.S.'s
FDA. To share compliance information, and to facilitate
inspections of handling facilities and growing areas for
shellfish products exported to the U.S. |
